These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 35401669)
1. Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells. Hasuike Y; Mochizuki H; Nakamori M Front Genet; 2022; 13():865811. PubMed ID: 35401669 [TBL] [Abstract][Full Text] [Related]
2. Cellular Senescence and Aging in Myotonic Dystrophy. Hasuike Y; Mochizuki H; Nakamori M Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216455 [TBL] [Abstract][Full Text] [Related]
3. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy. Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670 [TBL] [Abstract][Full Text] [Related]
4. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374 [TBL] [Abstract][Full Text] [Related]
5. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1. Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464 [TBL] [Abstract][Full Text] [Related]
6. A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1. Jahromi AH; Nguyen L; Fu Y; Miller KA; Baranger AM; Zimmerman SC ACS Chem Biol; 2013 May; 8(5):1037-43. PubMed ID: 23480597 [TBL] [Abstract][Full Text] [Related]
7. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model. Angelbello AJ; Rzuczek SG; Mckee KK; Chen JL; Olafson H; Cameron MD; Moss WN; Wang ET; Disney MD Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7799-7804. PubMed ID: 30926669 [TBL] [Abstract][Full Text] [Related]
8. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy. Sobczak K; Wheeler TM; Wang W; Thornton CA Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533 [TBL] [Abstract][Full Text] [Related]
9. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels. Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586 [TBL] [Abstract][Full Text] [Related]
10. Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Chakraborty M; Sellier C; Ney M; Pascal V; Charlet-Berguerand N; Artero R; Llamusi B Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29592894 [TBL] [Abstract][Full Text] [Related]
11. Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene. Llamusí B; Artero R Curr Genomics; 2008 Dec; 9(8):509-16. PubMed ID: 19516957 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Osborne RJ; Lin X; Welle S; Sobczak K; O'Rourke JR; Swanson MS; Thornton CA Hum Mol Genet; 2009 Apr; 18(8):1471-81. PubMed ID: 19223393 [TBL] [Abstract][Full Text] [Related]
13. Study of an RNA-Focused DNA-Encoded Library Informs Design of a Degrader of a r(CUG) Repeat Expansion. Gibaut QMR; Akahori Y; Bush JA; Taghavi A; Tanaka T; Aikawa H; Ryan LS; Paegel BM; Disney MD J Am Chem Soc; 2022 Dec; 144(48):21972-21979. PubMed ID: 36399603 [TBL] [Abstract][Full Text] [Related]
14. Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells. Bigot A; Klein AF; Gasnier E; Jacquemin V; Ravassard P; Butler-Browne G; Mouly V; Furling D Am J Pathol; 2009 Apr; 174(4):1435-42. PubMed ID: 19246640 [TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997 [TBL] [Abstract][Full Text] [Related]
16. Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects. Hoskins JW; Ofori LO; Chen CZ; Kumar A; Sobczak K; Nakamori M; Southall N; Patnaik S; Marugan JJ; Zheng W; Austin CP; Disney MD; Miller BL; Thornton CA Nucleic Acids Res; 2014 Jun; 42(10):6591-602. PubMed ID: 24799433 [TBL] [Abstract][Full Text] [Related]
17. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2). Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272 [TBL] [Abstract][Full Text] [Related]
18. Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG) Gibaut QMR; Bush JA; Tong Y; Baisden JT; Taghavi A; Olafson H; Yao X; Childs-Disney JL; Wang ET; Disney MD ACS Cent Sci; 2023 Jul; 9(7):1342-1353. PubMed ID: 37521782 [TBL] [Abstract][Full Text] [Related]